Embecta Corp. provided earnings guidance for the fiscal year 2024. For the year, the company expects revenues to be $1,111 million -$1,116 million against previous guidance of $1,094 million- $1,116 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.09 USD | -0.30% | -4.38% | -30.85% |
May. 16 | Transcript : Embecta Corp. Presents at Bank of America Health Care Conference 2024, May-16-2024 10:00 AM | |
May. 09 | Health Care Climbs as Obesity-Drug Optimism Returns - Health Care Roundup | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.22% | 757M | |
-7.44% | 181B | |
-0.38% | 108B | |
-6.86% | 66.12B | |
+2.52% | 50.65B | |
+5.29% | 43.11B | |
+3.49% | 40.74B | |
+19.70% | 31.6B | |
+16.38% | 25.56B | |
-7.23% | 24.16B |
- Stock Market
- Equities
- EMBC Stock
- News Embecta Corp.
- Embecta Corp. Provides Earnings Guidance for the Fiscal Year 2024